Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin could hit $95K-$100K by year-end despite MSCI index exclusion risks.

Market News
16 Oct 2026
Tokenpost
View Source
Neutral
Bitcoin could hit $95K-$100K by year-end despite MSCI index exclusion risks.

Sean Ferrell of Fundstrat Global Advisors says the risk of MSCI excluding Bitcoin treasury companies from its indexes is mostly priced in, limiting downside impact. While an exclusion could cause a short-term negative reaction, it is unlikely to disrupt the market significantly. Improved financials of Bitcoin treasury companies and easing macroeconomic conditions support Bitcoin's resilience. Ferrell expects Bitcoin to potentially reach $95,000 to $100,000 by year-end, despite not returning to its all-time high soon.

The story on MSCI exclusion risk and Bitcoin price outlook offers context for cryptocurrency market activity on Pluang. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 16, 2026 23:21 WIB: Among 50 priced major cryptocurrencies, 25 rose and 24 fell today. BAL (Balancer) led with a 1-day gain of +11.14% at Rp16.297 and a typical hold time of 85 days, outperforming EOS (EOS.IO) which rose +8.13% to Rp12.649 with an 87-day hold, and FIL (Filecoin) which increased +8.09% to Rp21.071, with a typical hold time of 100 days and a slightly higher buy order activity at 53%.

More News

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

New crypto Pepeto raises $11.23M amid Ethereum's bullish $10,000 price forecast for 2026.

Pepeto, a new cryptocurrency on the Ethereum network, has quickly raised over $11.23 million in its presale, with each funding stage closing faster than the last. This momentum comes as Ethereum is predicted to reach $10,000 by the end of 2026, drive...

Market News
Bullish
36 minutes ago
BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.

BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

Market News
Neutral
1 hour ago
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.

Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

Market News
Bullish
1 hour ago
K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.

K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

Market News
Bullish
1 hour ago
BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock's stake in Fagron falls below 3% after share disposals, now holding 2.96% voting rights.

BlackRock, Inc. disclosed that its shareholding in Fagron NV dropped below the 3% threshold to 2.96% after selling some voting securities, despite acquiring equivalent financial instruments. As of October 12, 2026, BlackRock holds 2,015,779 voting ri...

Market News
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App